CooperCompanies to Present at Wells Fargo Healthcare Conference

CooperCompanies will participate in the Wells Fargo Healthcare Conference on September 3, 2025, with President and CEO Al White representing the company in a session at 3:00 PM ET. The webcast will be available on the company's website. CooperCompanies is a leading global medical device company with two business units, CooperVision and CooperSurgical, serving over 130 countries and impacting 50 million lives annually.

CooperCompanies (Nasdaq: COO), a leading global medical device company, has announced its participation in the upcoming Wells Fargo Healthcare Conference. President and CEO Al White will represent the company in a session scheduled for September 3, 2025, at 3:00 PM ET. Investors and interested parties can access the webcast through CooperCompanies' investor relations website at http://investor.coopercos.com.

CooperCompanies, headquartered in San Ramon, CA, is focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, while CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. With a workforce of over 16,000, the company sells products in over 130 countries and positively impacts over fifty million lives each year.

The Wells Fargo Healthcare Conference is a significant event for the healthcare industry, providing a platform for industry leaders to discuss the latest trends, innovations, and challenges. CooperCompanies' participation in this conference reflects its commitment to staying at the forefront of medical device technology and its dedication to improving patient outcomes globally.

In addition to its participation in the conference, CooperCompanies is also experiencing growth in its assisted reproductive technology (ART) market segment. The United States ART market is projected to grow from US$ 6.01 billion in 2024 to US$ 9.31 billion by 2033, with a CAGR of 4.98% from 2025 [2]. Key drivers for this growth include rising infertility rates, technological advancements, increased acceptance of fertility treatments, and enhanced insurance and genetic testing. Despite these growth drivers, high costs and regulatory challenges remain significant barriers to the market.

CooperCompanies' involvement in the Wells Fargo Healthcare Conference will provide an opportunity for the company to share its latest innovations and strategies with industry stakeholders. The webcast will be available to investors and other interested parties, allowing them to engage with the company's leadership and gain insights into its future plans.

References:
[1] https://www.stocktitan.net/news/COO/cooper-companies-to-participate-in-the-wells-fargo-healthcare-c5wab6uqyeyc.html
[2] https://finance.yahoo.com/news/us-assisted-reproductive-technology-market-095600545.html